Sepsis Diagnostic Market Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Page 1

SEPSIS DIAGNOSTIC MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027

© Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Sepsis Diagnostic Market - Overview Sepsis Diagnostic Market, By Product (Assay and Reagents, Blood Culture Media, and Instruments), By Pathogen (Fungal Sepsis and Bacterial Sepsis), By Method (Immunoassays, Flow Cytometry, Molecular Diagnosis, and Biomarker Diagnosis), By Diagnostic Method (Conventional and Automated), By End User (Hospital Laboratories, Diagnostic Laboratories, Academic and Research Laboratories) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 Sepsis is life threatening complication caused due to the infection, which can result into organ failure, tissue damage, and ultimately lead to death if left untreated. If sepsis progresses to septic shock, it cause sudden drop in blood pressure and may leads to death of patient. Patients suffering from impaired immune system due to illness or drugs, cancer treatment with chemotherapy, splenectomy, sickle cell disease, and people who consume steroids and immunosuppressant drugs are prone to sepsis. The symptoms associated with sepsis includes high fever with temperature above 1010 F or temperature below 96.8 F, increased heart rate to 90 beats per minute, high breathing rate to around 20 breaths per minute, tissue swelling and confirmed infection. According to the Healthcare Cost and Utilization Project (HCUP) report submitted by Agency for Healthcare Research and Quality (AHRQ) in 2016, septicemia accounted for the leading cause of hospitalization in the U.S., owing to consuming more than US$ 24 billion each year. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing-insight/sepsisdiagnostic-market-1166 Š Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Increasing prevalence of sepsis is resulting into high demand for sepsis diagnostic devices in the market. According to the World Health Organization 2018 statistics, sepsis affected over 30 million people worldwide and more than 3 million newborns and 1.2 million children suffers from sepsis globally each year. According to the Sepsis Alliance report 2016, sepsis affects over 26 million people worldwide and more than 5 million children each year. According to the Centers for Disease Control and Prevention (CDC), more than 1.5 million people in the U.S. suffer from sepsis annually and around 2,50,000 Americans die each year due to sepsis. The treatment includes rapid administration of antibiotic and intravenous fluid (IV fluid) to the patient detected with symptoms of sepsis, as the risk of death form sepsis increases by 7.6% with every hour from the time of treatment begins. Antibiotic treatment mainly includes broad spectrum antibiotic given by intravenous. The antibiotics used in the sepsis treatment includes vancomycin, piperacillin, tazobactam, cefepime, tobramycin, and aztreonam. F.Hoffmann-La Roche in June 2016 receives the FDA clearance for its Procalcitonin (PCT) assay, which helps clinicians to effectively assist sepsis risk and manage sepsis patients. The assay provides the testing solution for people with severe sepsis or septic shock. Roche is the first company from U.S. to provide fully integrated solution for sepsis risk assessment and management. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/1166 Š Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Singulex, Inc. an immunodiagnostic company engaged in developing single molecule counting (SMC) technology for clinical diagnosis and scientific research, in December 2016 signed a license and supply agreement with Thermo Fisher Scientific Inc. The agreement allows Singulex access to Thermo Fisher’s BRAHMS PCT biomarker, which is used to diagnose systemic bacterial infection and treatment of sepsis in Europe. Recent advances in product development and rising product approval is expected to drive the market over the forecast period. For instance in May 2018, T2 Biosystems, a U.S. based Biotechnology Company providing in-vitro diagnostics, received U.S. Food and Drug Administration approval for its bacterial sepsis panel called T2Bacteria. In February 2017 Immunexpress a technology based company provides solutions for sepsis diagnostics, received U.S. Food and Drug Administration approval for the SeptiCyte test as an aid in differentiating patients that have sepsis caused due to systemic inflammatory response syndrome (SIRS) Some of the key players operating in the sepsis diagnostic market includes BioMerieux SA, Cepheid, Thermo Fisher Scientific Inc., T2 Biosystems, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd, Luminex Corporation, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc. Buy-Now this Research Report @

https://www.coherentmarketinsights.com/insight/buy-now/1166 Š Coherent market Insights. All Rights Reserved


ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.

SERVICES INDUSTRY ANALYSIS

CUSTOMIZED RESEARCH

SYNDICATED RESEARCH

MARKET INTELLIGENCE SERVICES

CONSULT STUDIES

COUNTRY SPECIFIC STUDIES

Š Coherent market Insights. All Rights Reserved


ABOUT CMI SECTOR COVERAGE

BIOTECHNOLOGY

CLINICAL DIAGNOSTIC

HEALTHCARE IT

MEDICAL DEVICES

MEDICAL IMAGING

PHARMACEUTICAL

OUR CLIENTS

 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators

 Private and Government organization

 Distributors, Retailors and Value Added Resellers

 Outsourcing Companies

 Healthcare IT Solutions Developers

 Universities and Business Schools.

© Coherent market Insights. All Rights Reserved


KEY STATS

RESEARCH SOLUTIONS

100+

FEASIBILITY STUDIES

Insights Published Per Year

GLOBAL REPORTS

150+

Consulting Projects Till Date

COUNTRY ANALYSIS CONSULT PROJECTS

125+

Clients Worldwide Per Year

110+

SURVEY RESEARCH

EXCEL FORECAST DATABASE

CUSTOMIZED SOLUTIONS

COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved


THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

Š Coherent market Insights. All Rights Reserved


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.